Halda Therapeutics is a startup based in the United States, most recent round Acquired, 1 tracked investor.
Based in the United States, Halda Therapeutics is a startup. Halda Therapeutics has been acquired. Brouky records 1 investor associated with the company.
Halda Therapeutics develops RIPTAC therapeutics, a novel class of precision cancer medicines that selectively kill cancer cells by inducing targeted protein-protein interactions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.